Cancer Targeted Drug Delivery
Cancer Targeted Drug Delivery
复制标题
DOI:
10.1007/978-1-4614-7876-8
复制
发表时间:
2013-07
期刊:
影响因子:
--
通讯作者:
Y. Bae;R. Mrsny;Kinam Park
中科院分区:
文献类型:
--
作者:
Y. Bae;R. Mrsny;Kinam Park
Cancer is something that nobody welcomes. Yet, it visits us randomly. Once cancer shows up on our doorstep, it just won’t go away. It would be nice if we can figure out why and when cancer decides to visit any one of us. Cancer treatment has become more effective over the years, at least for some cancers, but overall cancer is seldom curable. Developing new effective drugs is important, but most drugs have side effects. The drug is useful as long as the benefit is larger than the side effects, but having the drug without side effects is the ultimate goal. One of the functions of drug delivery systems is to minimize the side effects while maximizing the pharmacological efficacy.While current drug delivery systems have shown promising results in increasing the benefit/risk ratio, the technology has to be improved substantially. Thus, we ask a simple, yet fundamental, question: why is it so difficult to cure cancer? Cancer is not a single disease that can be eradicated by a single drug. Cancer occurs for a variety of reasons and no two cancers are identical. To improve our chances of treating cancers successfully, depending on how we define “successful,” we need to understand cancer better. As Sun Tzu pointed out in his famous book, The Art of War, winning the battles requires knowing the enemy and ourselves. President Nixon declared the war on cancer, ie, signed the National Cancer Act, in 1971, making cancer our enemy. This enemy is derived from our own cells, and unfortunately, is evasive as well as evolving; thus winning the battle becomes complicated. To know ourselves means knowing our current technologies on delivery of anticancer agents. One of our goals of editing this book was to define our enemy more clearly and understand our own ability of targeted drug delivery better.